J. Earl

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

A. Schaefer, Shinn-Jang Hwang, G. Icardi, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Diane M. Miller, Natalia E. Shilkina, M. C. Cantero, 2018, Lancet.

An Isocratic UV HPLC Assay for Analysis of Total and Free Melphalan Concentrations in Human Plasma

J. Trotman, L. Zeng, A. Eslick, 2008 .

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.

I. Kerridge, Peter Shaw, C. Tiley, 2010, British journal of clinical pharmacology.

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Hyo Youl Kim, Kenjiro Nakamura, A. Schaefer, 2022, Open forum infectious diseases.

An HPLC-UV method for determining plasma dimethylacetamide concentrations in patients receiving intravenous busulfan.

Samiuela Lee, J. Byrne, Parth Upadhyay, 2017, Biomedical chromotography.